Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cellsCOPPO, Paul; DUSANTER-FOURT, Isabelle; SAINTENY, Francoise et al.Oncogene (Basingstoke). 2003, Vol 22, Num 26, pp 4102-4110, issn 0950-9232, 9 p.Article

BCR―ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patientsDE CARVALHO, D. D; BINATO, R; CASTRO, F. A et al.Oncogene (Basingstoke). 2011, Vol 30, Num 2, pp 223-233, issn 0950-9232, 11 p.Article

Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cellsESSAFI, Abdelkader; FERNANDEZ DE MATTOS, Silvia; HASSEN, Yasmin A. M et al.Oncogene (Basingstoke). 2005, Vol 24, Num 14, pp 2317-2329, issn 0950-9232, 13 p.Article

The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblastsDALEY, G. Q; MCLAUGHLIN, J; WITTE, O. N et al.Science (Washington, D.C.). 1987, Vol 237, Num 4814, pp 532-535, issn 0036-8075Article

Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemiaARLINGHAUS, Ralph B.Oncogene (Basingstoke). 2002, Vol 21, Num 56, pp 8560-8567, issn 0950-9232, 8 p.Article

Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell linesDESPLAT, Vanessa; BELLOC, Francis; LAGARDE, Valkrie et al.Cancer. 2005, Vol 103, Num 1, pp 102-110, issn 0008-543X, 9 p.Article

Interphase FISH for follow-up of Philadelphia chromosome-positive chronic myeloid leukemia treatmentDOUET-GUILBERT, Nathalie; MOREL, Frédéric; LE CHARPENTIER, Tiffen et al.Anticancer research. 2004, Vol 24, Num 4, pp 2535-2539, issn 0250-7005, 5 p.Article

AMNI07 (nilotinib) : a novel and selective inhibitor of BCR-ABLWEISBERG, E; MANLEY, P; MESTAN, I et al.British journal of cancer. 2006, Vol 94, Num 12, pp 1765-1769, issn 0007-0920, 5 p.Article

Rin1 is a negative regulator of the IL3 receptor signal transduction pathwaysHUNKER, C. M; GALVIS, A; VEISAGA, M. L et al.Anticancer research. 2006, Vol 26, Num 2A, pp 905-916, issn 0250-7005, 12 p.Article

WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cellsELMAAGACLI, Ahmet H; KOLDEHOFF, Michael; PECENY, Rudolf et al.Haematologica (Roma). 2005, Vol 90, Num 3, pp 326-334, issn 0390-6078, 9 p.Article

Inhibition of phosphorylation of p160 BCR within p210 BCR-ABL complexes during early stages of phorbol ester-induced differentiation of K562 cellsCAMPBELL, P. L; DAI LU; JIE QIANG GUO et al.Cell growth and differentiation. 1993, Vol 4, Num 7, pp 581-588, issn 1044-9523Article

The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemiaLIHUI WANG; KNIGHT, Katy; LUCAS, Claire et al.Haematologica (Roma). 2006, Vol 91, Num 2, pp 235-239, issn 0390-6078, 5 p.Article

Bcr-Abl induces autocrine IGF-1 signalingLAKSHMIKUTTYAMMA, A; PASTURAL, E; TAKAHASHI, N et al.Oncogene (Basingstoke). 2008, Vol 27, Num 27, pp 3831-3844, issn 0950-9232, 14 p.Article

In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CMLWHITE, Deborah; SAUNDERS, Verity; LYONS, A. Bruce et al.Blood. 2005, Vol 106, Num 7, pp 2520-2526, issn 0006-4971, 7 p.Article

The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cellsAICHBERGER, Karl J; MAYERHOFER, Matthias; PICKL, Winfried F et al.Blood. 2006, Vol 108, Num 10, pp 3538-3547, issn 0006-4971, 10 p.Article

STAT5 signaling is required for the efficient induction and maintenance of CML in miceDAN YE; WOLFF, Nicholas; LI LI et al.Blood. 2006, Vol 107, Num 12, pp 4917-4925, issn 0006-4971, 9 p.Article

Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristicsBAIJUN FANG; CHUNMEI ZHENG; LIANMING LIAO et al.Blood. 2005, Vol 105, Num 7, pp 2733-2740, issn 0006-4971, 8 p.Article

The development of imatinib as a therapeutic agent for chronic myeloid leukemiaDEININGER, Michael; BUCHDUNGER, Elisabeth; DRUKER, Brian J et al.Blood. 2005, Vol 105, Num 7, pp 2640-2653, issn 0006-4971, 14 p.Article

BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapyJIE QIANG GUO; JIN YING LIAN; YONG MING XIAN et al.Blood. 1994, Vol 83, Num 12, pp 3629-3637, issn 0006-4971Article

Expression of bcr and bcr-abl fusion transcripts in normal and leukemic cellsCOLLINS, S; COLEMAN, H; GROUDINE, M et al.Molecular and cellular biology (Print). 1987, Vol 7, Num 8, pp 2870-2876, issn 0270-7306Article

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused geneSHTIVELMAN, E; LIFSHITZ, B; GALE, R. P et al.Cell (Cambridge). 1986, Vol 47, Num 2, pp 277-284, issn 0092-8674Article

Assessment of downstream effectors of BCR/ABL protein tyrosine kinase using combined proteomic approachesCHIA FANG LEE; GRIFFITHS, Stephen; RODRIGUEZ-SUAREZ, Eva et al.Proteomics (Weinheim. Print). 2010, Vol 10, Num 18, pp 3321-3342, issn 1615-9853, 22 p.Article

Differential motility of p190^bcr-abl-and p210^bcr-ahl-expressing cells : respective roles of Vav and Bcr-Abl GEFsDAUBON, T; CHASSERIAU, J; EL ALI, A et al.Oncogene (Basingstoke). 2008, Vol 27, Num 19, pp 2673-2685, issn 0950-9232, 13 p.Article

Chronic myelogenous leukemia molecular signatureNOWICKI, Michal Oskar; PAWLOWSKI, Peter; FISCHER, Thomas et al.Oncogene (Basingstoke). 2003, Vol 22, Num 25, pp 3952-3963, issn 0950-9232, 12 p.Article

Graphene sheets, polyaniline and AuNPs based DNA sensor for electrochemical determination of BCR/ABL fusion gene with functional hairpin probeLI WANG; ERHUI HUA; MO LIANG et al.Biosensors & bioelectronics. 2014, Vol 51, pp 201-207, issn 0956-5663, 7 p.Article